More men with advanced prostate cancer could benefit from immunotherapy with sipuleucel-T, according to researchers who found use of the drug was influenced by income and other factors.
Reuters Health Information
Original Article: Sipuleucel-T Could Be More Widely Used for Advanced Prostate Cancer